Epidermolysis bullosa acquisita

An Bras Dermatol. 2022 Jul-Aug;97(4):409-423. doi: 10.1016/j.abd.2021.09.010. Epub 2022 Jun 11.


Epidermolysis bullosa acquisita is a rare autoimmune disease, characterized by the synthesis of anti-collagen VII autoantibodies, the main component of hemidesmosome anchoring fibrils. The antigen-antibody binding elicits a complex inflammatory response, which culminates in the loss of dermo-epidermal adhesion of the skin and/or mucous membranes. Skin fragility with bullae, erosions, and milia in areas of trauma characterizes the mechanobullous form of the disease. In the inflammatory form of epidermolysis bullosa acquisita, urticarial inflammatory plaques with tense bullae, similar to bullous pemphigoid, or mucosal lesions can determine permanent scars and loss of functionality in the ocular, oral, esophageal, and urogenital regions. Due to the similarity of the clinical findings of epidermolysis bullosa acquisita with other diseases of the pemphigoid group and with porphyria cutanea tarda, the diagnosis is currently confirmed mainly based on the clinical correlation with histopathological findings (pauci-inflammatory subepidermal cleavage or with a neutrophilic infiltrate) and the demonstration of the presence of anti-collagen VII IgG in situ by direct immunofluorescence, or circulating anti-collagen VII IgG through indirect immunofluorescence and/or ELISA. There is no specific therapy for epidermolysis bullosa acquisita and the response to treatment is variable, usually with complete remission in children and a worse prognosis in adults with mucosal involvement. Systemic corticosteroids and immunomodulators (colchicine and dapsone) are alternatives for the treatment of mild forms of the disease, while severe forms require the use of corticosteroid therapy associated with immunosuppressants, intravenous immunoglobulin, and rituximab.

Keywords: Autoimmunity; Epidermolysis bullosa acquisita; Vesiculobullous skin diseases.

MeSH terms

  • Adult
  • Autoantibodies
  • Autoimmune Diseases*
  • Blister
  • Child
  • Epidermolysis Bullosa Acquisita* / diagnosis
  • Epidermolysis Bullosa Acquisita* / drug therapy
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Pemphigoid, Bullous* / drug therapy


  • Autoantibodies
  • Immunoglobulins, Intravenous